+ All Categories
Home > Health & Medicine > 2003 cvs shifa permeation through biological membranes

2003 cvs shifa permeation through biological membranes

Date post: 31-May-2015
Category:
Upload: muhammad-saim
View: 417 times
Download: 3 times
Share this document with a friend
Popular Tags:
12
Cardiovascular System- Theme 1 Dr. Fahad Azam Pharmacology and Therapeutics
Transcript
Page 1: 2003 cvs shifa permeation through biological membranes

Cardiovascular System-Theme 1

Dr. Fahad AzamPharmacology and Therapeutics

Page 2: 2003 cvs shifa permeation through biological membranes

THEME 1: BREATHLESSNESS AND SWELLING (CCF)

• CASE 1• A 64 years old male with heart failure was put on digoxin therapy in tablet form, formulated by XYZ

pharmaceutical. Initially he was given 0.5mg 8 hourly for three days followed by 0.125mg/day. Simultaneously he was suffering from severe cough, fever and malaise, the physician after thorough investigations diagnosed him as a case of lower respiratory tract infection and prescribed 100mgday doxycycline initially for one week which was further extended to 10 days. The patient suffered from diarrhea, doxycycline was discontinued, a course of metronidazole was given and patient got cured.

• • After few days patient presented with complaints of nausea, vomiting, fatigue, palpitations. The

dose of digoxin was increased to 0.25 mg/day and he felt better.• • After few years he was diagnosed for chronic renal failure, blood urea and creatinine were raised.

He developed heart sinking and palpitation. On examination, the patient had an irregular pulse. ECG showed pulses bigeminy. Serum digoxin was 2.8 ng/ml. Digoxin therapy was stopped for three days. KCI was administered for few days. The plasma level was now repeated and was 1ng/ml. The dose of digoxin was adjusted to 0.125 mg /day. The patient became stable in a week.

Page 3: 2003 cvs shifa permeation through biological membranes

LEARNING OBJECTIVES

1. Describe general principles of pharmacology, sources of drugs, routes of drug administration, Essential Drugs concept.

2. Describe drug transport across biological membranes.3. Relate concepts of half life of drug, plasma protein binding drug and volume of

distribution of drugs to its bioavailability.4. Describe loading dose, steady state concentration, target concentration and

maintenance concentration and bioequivalence of drugs.5. Describe drug excretion, clearance, zero and first order kinetic of drugs.6. Relate drug metabolism, factors affecting drug metabolism and its clinical

significance.7. Relate drug receptor concepts, antagonism, synergism, drug-receptor interaction

and signaling mechanism of drugs.8. Define relation between drug concentration and response and define drug

response curves (graded and quantal).9. Describe dose response curves, pharmacokinetic and pharmacodynamic drug

interactions, drug toxicity, therapeutic index and therapeutic window.

Page 4: 2003 cvs shifa permeation through biological membranes
Page 5: 2003 cvs shifa permeation through biological membranes

Modes of Transport Across Biological Membranes

Mechanism Direction Energy Required Carrier Saturable

Passive diffusion Down gradient No No No

Facilitated diffusion

Down gradient No Yes Yes

Active transport Against gradient(concentration/electrical)

Yes Yes Yes

Page 6: 2003 cvs shifa permeation through biological membranes

Drug permeation is dependent on:

• Fick’s law of Diffusion:– Solubility– Concentration gradient– Surface area – Vascularity– Thickness

Page 7: 2003 cvs shifa permeation through biological membranes

Henderson-Hasselbalch equation

[protonated]

[unprotonated ]

log ______________ = pKa -pH

Page 8: 2003 cvs shifa permeation through biological membranes

• Drugs are either weak bases or weak acids (depending on their pKa) and can exist in either ionized or non ionized form (depending on their pKa and pH of the environment)

• Ionized = water soluble• Non ionized = lipid soluble

Page 9: 2003 cvs shifa permeation through biological membranes

• pKa is the intrinsic value of a drug, it does not change

• pKa is the pH at which the drug or molecule is 50% ionized and 50 % non ionized

Page 10: 2003 cvs shifa permeation through biological membranes

Clinical Application of Henderson-Hasselbalch Equation

• Ionization increases renal clearance of Drugs• Only free, unbound drug is filtered• Both ionized and nonionized forms of drug are filtered• Non ionized forms are reabsobred whereas ionized

forms are non absorbed as they have a charge and cannot pass through lipid membranes (lipid insoluble)

• Ionized forms of drugs are “trapped” in the filtrate

Page 11: 2003 cvs shifa permeation through biological membranes

Clinical Application of Henderson-Hasselbalch Equation

• Both ionized and nonionized forms of drug are filtered• Non ionized forms are reabsobred whereas ionized

forms are non absorbed as they have a charge and cannot pass through lipid membranes (lipid insoluble)

• Ionized forms of drugs are “trapped” in the filtrate• Acidification of urine increases ionization of weak

bases increases renal elimination• Alkalinization of urine increases ionization of weak

acids increases renal elimination

Page 12: 2003 cvs shifa permeation through biological membranes

To Change Urinary pH

• Acidify: NH4Cl, Vitamin C, Cranberry juice

• Alkalinize: NaHCO3, Acetazolamide


Recommended